| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.039 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |